nach oben

Erschienen in:

23.10.2020 | Review Article

Physical exercise protocols in animal models of Alzheimer’s disease: a systematic review

verfasst von: Ricardo Augusto Leoni De Sousa, Cíntia Maria Rodrigues, Bruno Ferreira Mendes, Alex Cleber Improta-Caria, Marco Fabrício Dias Peixoto, Ricardo Cardoso Cassilhas

Erschienen in: Metabolic Brain Disease | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Several animal studies have showed the beneficial effects of physical exercise (PE) on brain function and health. Alzheimer’s Disease (AD) is the most common type of dementia, characterized by the presence of aggregated extracellular amyloid-beta (Aβ) and neurofibrillary tangles, with progressive cognitive decline. Therapeutic approaches such as PE showed to be effective in halting AD progression. Here, we present a systematic review about PE and AD. The search was carried out using the PubMed and LILACS databases. The following keywords were used: Alzheimer; PE; animal model. All found studies adopted aerobic exercise training as the PE protocol (100%). We identified running on treadmill as the most commonly used PE routine (62.5%). The duration of each session, intensity, frequency, and period of training most used were 60 min/day (62.5%), moderate intensity (87.5%), 5 days/week (62.5%), and 4 (37.5%) or 12 (37.5%) weeks, respectively. The AD animal models most used were the Tg APP/PS1ΔE9 (25%), models based on i.c.v. infusion of AβOs (25%) and streptozotocin (25%). All protocols used rodents to their experiments (100%), but mice were the most common (62.5%). Finally, the main results presented in all studies were capable to reduce significantly AD consequences, such as reducing Aβ or pro-inflammatory proteins levels (100%). The lack of resistance training protocols in animal models of AD indicates a huge gap that should be investigated in future studies. We suggest that PE protocols must be adapted according to the specie, lineage and life span of the animal.

Alkadhi KA, Dao AT (2018) Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer’s disease. Mol Cell Neurosci 86:25–29. https://doi.org/10.1016/j.mcn.2017.11.008CrossRefPubMed

Barnes DE, Yaffe K (2011) The projected impact of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 10:S1474–S4422. https://doi.org/10.1093/milmed/166.4.331CrossRef

Batista AF, Frony-Germano L, Clarke JR, Silva NMLE, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF, Marques SA, Martinez AM, Gralle M, Holscher C, Klein WL, Houzel J-C, Ferreira ST, Munoz DP, De Felice FG (2018) The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer’s disease. J. Pathol. 245:85–100. https://doi.org/10.1002/path.5056CrossRefPubMedPubMedCentral

Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU, Johnson FB, Trojanowski JQ, Sell C, Torres C (2012) Astrocyte senescence as a component of Alzheimer’s disease. PLoS One 7:1–10. https://doi.org/10.1371/journal.pone.0045069CrossRef

Biessels GJ, Reagan LP (2015) Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci 16:660–671. https://doi.org/10.1038/nrn4019CrossRefPubMed

Bomfim TR, Forny-germano L, Sathler LB, Brito-moreira J, Houzel J, Decker H, Silverman MA, Kazi H, Melo HM, Mcclean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. J Clin Invest 122:1339–1353. https://doi.org/10.1172/JCI57256DS1CrossRefPubMedPubMedCentral

Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Zingaretti MC, Vind BF, Tu H, Cinti S, Gygi SP, Spiegelman BM (2012) A PGC1a dependent myokine that derives browning of white fat and thermogenesis. Nature 481:463–468. https://doi.org/10.1038/nature10777.ACrossRefPubMedPubMedCentral

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259. https://doi.org/10.1109/ICINIS.2015.10CrossRefPubMed

Brito-Moreira J, Lourenco MV, Oliveira MM, Ribeiro FC, Ledo JH, Diniz LP, Vital JFS, Magdesian MH, Melo HM, Barros-Aragão F, De Souza JM, Alves-Leon SV, Gomes FCA, Clarke JR, Figueiredo CP, De Felice FG, Ferreira ST (2017) Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice. J Biol Chem 292:7327–7337. https://doi.org/10.1074/jbc.M116.761189CrossRefPubMedPubMedCentral

Camandola S, Mattson M (2017) Brain metabolism in health , aging , and neurodegeneration. EMBO J. 36:1–19. https://doi.org/10.15252/embj.201695810CrossRef

Cassilhas RC, Tufik S, De Mello MT (2016) Physical exercise, neuroplasticity, spatial learning and memory. Cell Mol Life Sci 73:975–983. https://doi.org/10.1007/s00018-015-2102-0CrossRefPubMed

Craft S, Watson GS (2004) Review insulin and neurodegenerative disease : shared and specific mechanisms. Lancet Neurol 3:169–178CrossRef

De Felice FG, Ferreira ST (2014) Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes. 63:2262–2272. https://doi.org/10.2337/db13-1954CrossRefPubMed

De Felice FG, Vieira M, Bomfim T, Decker H, Velasco P, Lambert M, Viola K, Zhao W-W, Ferreira S, Klein W (2009) Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A 106:1971–1976. https://doi.org/10.1073/pnas.0809158106CrossRefPubMedPubMedCentral

De Felice FG, Lourenco MV, Ferreira ST (2014) How does brain insulin resistance develop in Alzheimer’s disease? Alzheimers Dement 10:S26–S32. https://doi.org/10.1016/j.jalz.2013.12.004CrossRefPubMed

De Sousa RAL, Harmer AR, Freitas DA, Mendonça VA, Lacerda ACR, Leite HR (2020) An update on potential links between type 2 diabetes mellitus and Alzheimer’s disease. Mol Biol Rep 47:6347–6356. https://doi.org/10.1007/s11033-020-05693-zCrossRefPubMed

Di Liegro CM, Schiera G, Proia P, Di Liegro I (2020) Physical activity and brain health. Genes (Basel) 10:1–40. https://doi.org/10.3389/fphys.2019.01550CrossRef

Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 9:1118–1127. https://doi.org/10.1016/S1474-4422(10)70223-4CrossRefPubMed

Dutta S, Sengupta P (2016) Men and mice: relating their ages. Life Sci 152:244–248. https://doi.org/10.1016/j.lfs.2015.10.025CrossRefPubMed

Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D (2018) Randomized trial of Verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med 378:1691–1703. https://doi.org/10.1056/NEJMoa1706441CrossRefPubMedPubMedCentral

Farshbaf MJ, Ghaedi K, Megraw TL (2015) Does PGC1 a / FNDC5 / BDNF elicit the beneficial effects of exercise on neurodegenerative disorders? NeuroMolecular Med. https://doi.org/10.1007/s12017-015-8370-x

Ferreira ST, Gralle M (2007) Structure and functions of the human amyloid precursor protein : the whole is more than the sum of its parts. Prog Neurobiol 82:11–32. https://doi.org/10.1016/j.pneurobio.2007.02.001CrossRefPubMed

Ferreira ST, Klein WL (2011) The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease. Neurobiol. Learn. Mem. 96:529–543. https://doi.org/10.1016/j.nlm.2011.08.003CrossRefPubMedPubMedCentral

Ferreira LSS, Fernandes CS, Vieira MNN, De-Felice FG (2018) Insulin resistance in Alzheimer’s disease. Front Neurosci 12:1–11. https://doi.org/10.1016/j.trsl.2016.12.005CrossRef

Figueiredo CP, Clarke JR, Ledo JH, Ribeiro FC, Costa CV, Melo HM, Mota-Sales AP, Saraiva LM, Klein WL, Sebollela A, De Felice FG, Ferreira ST (2013) Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J. Neurosci. 33:9626–9634. https://doi.org/10.1523/JNEUROSCI.0482-13.2013CrossRefPubMedPubMedCentral

Folch J, Olloquequi J, Ettcheto M, Busquets O, Sánchez-López E, Cano A, Espinosa-Jiménez T, García ML, Beas-Zarate C, Casadesús G, Bulló M, Auladell C, Camins A (2019) The involvement of peripheral and brain insulin resistance in late onset Alzheimer’s dementia. Front Aging Neurosci 11:1–16. https://doi.org/10.3389/fnagi.2019.00236CrossRef

Forbes D, Thiesen EJ, Blake CM, Forbes S (2015) Exercise programs for people with dementia. Cochrane Database Syst. Rev. 132:1–12. https://doi.org/10.1590/1516-3180.20141323T2CrossRef

Forny-germano L, Lyra NM, Batista F, Brito-moreira J, Gralle XM, Boehnke SE, Coe BC, Lablans A, Marques SA, Martinez AMB, Klein WL, Houzel XJ, Ferreira ST, Munoz DP, De Felice FG (2014) Alzheimer ’ s disease-like pathology induced by amyloid- ␤ oligomers in nonhuman Primates. Neurobiol Dis 34:13629–13643. https://doi.org/10.1523/JNEUROSCI.1353-14.2014CrossRef

Freitas D, Rocha-vieira E, de Sousa RAL, Alvarenga B, Rocha-gomes A, Garcia B, Cassilhas RC, Mendonça VA, Camargos ACR, Lacerda AC, Leite HR (2019) High-intensity interval training improves cerebellar antioxidant capacity without affecting cognitive functions in rats. Behav Brain Res 376:1–7. https://doi.org/10.1016/j.bbr.2019.112181CrossRef

Füger P, Hefendehl JK, Veeraraghavalu K, Wendeln AC, Schlosser C, Obermüller U, Wegenast-Braun BM, Neher JJ, Martus P, Kohsaka S, Thunemann M, Feil R, Sisodia SS, Skodras A, Jucker M (2017) Microglia turnover with aging and in an Alzheimer’s model via long-term in vivo single-cell imaging. Nat Neurosci 20:1371–1376. https://doi.org/10.1038/nn.4631CrossRefPubMed

Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP (2011) Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43:1334–1359. https://doi.org/10.1249/MSS.0b013e318213fefbCrossRefPubMed

George EK, Hemachandra Reddy P (2019) Can healthy diets, regular exercise, and better lifestyle delay the progression of dementia in elderly individuals? J Alzheimers Dis 72:S37–S58. https://doi.org/10.3233/JAD-190232CrossRefPubMed

Gizaw M, Anandakumar P, Debela T (2017) A review on the role of Irisin in insulin resistance and type 2 diabetes mellitus. Aust J Pharm 20:235–242

Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116:1081–1093. https://doi.org/10.1161/CIRCULATIONAHA.107.185649CrossRefPubMed

Haskins M, Jones TE, Lu Q, Bareiss SK (2016) Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer’s disease. Neurosci Lett 610:165–170. https://doi.org/10.1016/j.neulet.2015.11.002CrossRefPubMed

Improta Caria AC, Nonaka CKV, Pereira CS, Soares MBP, Macambira SG, de Freitas Souza BS (2018) Exercise training-induced changes in microRNAs: beneficial regulatory effects in hypertension, type 2 diabetes, and obesity. Int. J. Mol. Sci. 19:1–36. https://doi.org/10.3390/ijms19113608CrossRef

Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM, Nair KS, Gygi SP, Spiegelman BM (2015) Detection and quantitation of circulating human Irisin by tandem mass spectrometry mark. Cell Metab 22:734–740. https://doi.org/10.1016/j.physbeh.2017.03.040CrossRefPubMedPubMedCentral

Kachur S, Chongthammakun V, Lavie CJ, De Schutter A, Arena R, Milani RV, Franklin BA (2017) Impact of cardiac rehabilitation and exercise training programs in coronary heart disease. Prog Cardiovasc Dis 60:103–114. https://doi.org/10.1016/j.pcad.2017.07.002CrossRefPubMed

Kadish I, Kumar A, Beitnere U, Jennings E, McGilberry W, van Groen T (2016) Dietary composition affects the development of cognitive deficits in WT and Tg AD model mice. Exp Gerontol 86:39–49. https://doi.org/10.1016/j.exger.2016.05.003CrossRefPubMedPubMedCentral

Koo JH, Kang EB, Oh YS, Yang DS, Cho JY (2017) Treadmill exercise decreases amyloid-β burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer’s disease. Exp Neurol 288:142–152. https://doi.org/10.1016/j.expneurol.2016.11.014CrossRefPubMed

Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, Younkin L, Hyman BT, Younkin S, Ashe KH (2002) Reversible memory loss in a mouse transgenic model of Alzheimer ’ s disease. J Neurosci 22:6331–6335CrossRef

Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807. https://doi.org/10.1523/JNEUROSCI.3501-06.2007CrossRefPubMedPubMedCentral

Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, Sathler LB, Brito-Moreira J, Amaral OB, Silva CA, Freitas-Correa L, Espírito-Santo S, Campello-Costa P, Houzel J-C, Klein WL, Holscher C, Carvalheira JB, Silva AM, Velloso LA, Munoz DP, Ferreira ST, De Felice FG (2013) TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys. Cell Metab. 18:831–843. https://doi.org/10.1016/j.cmet.2013.11.002CrossRefPubMed

Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, Gonçalves RA, Clarke JR, Beckman D, Staniszevski A, Berman H, Guerra LA, Forny-Germano L, Meier S, Wilcock DM, De Souza JM, Alves-Leon SV, Prado VF, Prado MAM, Abisambra JF, Troval-Moll F, Mattos P, Arancio O, Ferreira ST, De Felice FG (2019) Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat. Med. 25:165–175. https://doi.org/10.1038/s41591-018-0275-4CrossRefPubMedPubMedCentral

Lu Y, Dong Y, Tucker D, Wang R, Ahmed ME, Brann D, Zhang Q (2017) Treadmill exercise exerts streptozotocin- induced rat model of sporadic Alzheimer’s disease. J Alzheimers Dis 56:1469–1484. https://doi.org/10.1158/1940-6207.CAPR-14-0359.Nrf2-dependentCrossRefPubMedPubMedCentral

Mahmoud R, Wainwright SR, Galea LAM (2016) Sex hormones and adult hippocampal neurogenesis: regulation, implications, and potential mechanisms. Front Neuroendocrinol 41:129–152. https://doi.org/10.1016/j.yfrne.2016.03.002CrossRefPubMed

Melo CS, Rocha-Vieira E, Freitas DA, Soares BA, Rocha-Gomes A, Riul TR, Mendonça VA, Lacerda ACR, Camargos ACR, Carvalho LED, De Sousa RAL, Leite HR (2019) A single session of high-intensity interval exercise increases antioxidants defenses in the hippocampus of Wistar rats. Physiol Behav 211:112675. https://doi.org/10.1016/j.physbeh.2019.112675CrossRefPubMed

Moore KM, Girens RE, Larson SK, Jones MR, Restivo JL, Holtzman DM, Cirrito JR, Yuede CM, Zimmerman SD, Timson BF (2016) A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer’s disease. Neurobiol Dis 85:218–224. https://doi.org/10.1016/j.nbd.2015.11.004CrossRefPubMed

Neves FS, Marques PT, Aragão FB, Nunes JB, Venancio AM, Cozachenco D, Frozza RL, Passos GF, Costa R, De Oliveira J, Engel DF, De Bem AF, Benjamim CF, De Felice FG, Ferreira ST, Clarke JR, Figueiredo CP, Clarke JR (2016) Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice. Mol Neurobiol 55:1–10. https://doi.org/10.1007/s12035-016-0307-3CrossRef

Oskarsson ME, Paulsson JF, Schultz SW, Ingelsson M, Westermark P, Westermark GT (2015) In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and alzheimer disease. Am. J. Pathol. 185:834–846. https://doi.org/10.1016/j.ajpath.2014.11.016CrossRefPubMed

Özbeyli D, Sarı G, Özkan N, Karademir B, Yüksel M, Çilingir Kaya ÖT, Kasımay Çakır Ö (2017) Protective effects of different exercise modalities in an Alzheimer’s disease-like model. Behav Brain Res 328:159–177. https://doi.org/10.1016/j.bbr.2017.03.044CrossRefPubMed

Pedersen BK, Saltin B (2015) Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sport 25:1–72. https://doi.org/10.1111/sms.12581CrossRef

Physicians PC (2020) 2020 Alzheimer’s disease facts and figures. Alzheimers Dement 16:391–460. https://doi.org/10.1002/alz.12068CrossRef

Qaisar R, Bhaskaran S, Van Remmen H (2016) Muscle fiber type diversification during exercise and regeneration. Free Radic Biol Med 98:56–67. https://doi.org/10.1016/j.freeradbiomed.2016.03.025CrossRefPubMed

Querfurth HW, Laferla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344CrossRef

Roden M (2012) Exercise in type 2 diabetes: to resist or to endure? Diabetologia. 55:1235–1239. https://doi.org/10.1007/s00125-012-2513-5CrossRefPubMedPubMedCentral

Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, Stern Y (2009) Physical activity, diet, and risk of Alzheimer disease. JAMA – J Am Med Assoc 302:627–637. https://doi.org/10.1038/jid.2014.371CrossRef

Scarmeas N, Luchsinger JA, Brickman AM, Cosentino S, Schupf N, Xin-Tang M, Gu Y, Stern Y (2011) Physical activity and alzheimer disease course. Am J Geriatr Psychiatry 19:471–481. https://doi.org/10.1097/JGP.0b013e3181eb00a9CrossRefPubMedPubMedCentral

Shaik MM, Tamargo IA, Abubakar MB, Kamal MA, Greig NH, Gan SH (2018) The role of microRNAs in Alzheimer’s disease and their therapeutic potentials. Genes (Basel) 9. https://doi.org/10.3390/genes9040174

Soares FHR, de Sousa MBC (2013) Different types of physical activity on inflammatory biomarkers in women with or without metabolic disorders: a systematic review. Women Health 53:298–316. https://doi.org/10.1080/03630242.2013.782940CrossRefPubMed

Soreq L, Rose J, Soreq E, Hardy J, Trabzuni D, Cookson MR, Smith C, Ryten M, Patani R, Ule J (2017) Major shifts in glial regional identity are a transcriptional Hallmark of human brain aging. Cell Rep 18:557–570. https://doi.org/10.1016/j.celrep.2016.12.011CrossRefPubMedPubMedCentral

de Sousa RAL (2018) Brief report of the effects of the aerobic , resistance , and high-intensity interval training in type 2 diabetes mellitus individuals diabetes mellitus. Int J Diabetes Dev Ctries 38:138–145. https://doi.org/10.1007/s13410-017-0582-1CrossRef

Sousa RAL, Freitas DA, Leite HR (2019) Cross-talk between obesity and central nervous system: role in cognitive function. Interv. Obes. Diabetes 3:7–9. https://doi.org/10.31031/IOD.2019.03.000551CrossRef

Stomby A, Otten J, Ryberg M, Nyberg L, Olsson T, Boraxbekk CJ (2017) A paleolithic diet with and without combined aerobic and resistance exercise increases functional brain responses and hippocampal volume in subjects with type 2 diabetes. Front Aging Neurosci 9:1–10. https://doi.org/10.3389/fnagi.2017.00391CrossRef

Talbot K, Wang H, Kazi H, Han L, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in alzheimer’s disease patients is assocaited with IGF-1 resisitance, IRS-1 dysregulation, and cogntive decline. J. Clin. Invest. 122:1316–1338. https://doi.org/10.1172/JCI59903DS1CrossRefPubMedPubMedCentral

Tapia-Rojas C, Aranguiz F, Varela-Nallar L, Inestrosa NC (2016) Voluntary running attenuates memory loss, decreases Neuropathological changes and induces neurogenesis in a mouse model of Alzheimer’s disease. Brain Pathol 26:62–74. https://doi.org/10.1111/bpa.12255CrossRefPubMed

Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjærpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 115:3086–3094. https://doi.org/10.1161/CIRCULATIONAHA.106.675041CrossRefPubMed

World Health Organization (2017) Physical activity and older adults. Glob Strateg Diet Phys Act Heal

Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, Lin JD, Greenberg ME, Spiegelman BM (2013) Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab 18:649–659. https://doi.org/10.1016/j.cmet.2013.09.008CrossRefPubMedPubMedCentral

Wu C, Yang L, Tucker D, Dong Y, Zhu L, Duan R, Liu TC-Y, Zhang Q (2018) Beneficial effects of exercise pretreatment in a sporadic Alzheimer’s rat model. Med Sci Sports Exerc 50:945–956. https://doi.org/10.1016/j.physbeh.2017.03.040CrossRefPubMedPubMedCentral

Zhang J, Guo Y, Wang Y, Song L, Zhang R, Du Y (2018) Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer’s disease. Neurosci Lett 666:70–77. https://doi.org/10.1016/j.neulet.2017.12.025CrossRefPubMed

Titel: Physical exercise protocols in animal models of Alzheimer’s disease: a systematic review
verfasst von: Ricardo Augusto Leoni De Sousa
Cíntia Maria Rodrigues
Bruno Ferreira Mendes
Alex Cleber Improta-Caria
Marco Fabrício Dias Peixoto
Ricardo Cardoso Cassilhas
Publikationsdatum: 23.10.2020
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 1/2021
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-020-00633-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Current and emerging therapeutic targets for Parkinson’s disease

Mood disorders are associated with the reduction of brain derived neurotrophic factor in the hypocampus in rats submitted to the hipercaloric diet

Laterality and sex differences in the expression of brain-derived neurotrophic factor in developing rat hippocampus

Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates

Circulating sortilin levels are associated with inflammation in patients with moyamoya disease